The Takeda deal lets Insilico scale beyond its own pipeline

“points to Insilico's thirty one developmental candidates as proof its platform delivers real drugs, not just software”

“roughly sixty million upfront with the remaining six hundred million tied to milestones and royalties”

“In many ways, Lilly is better than us in some areas of AI”

“There has never been a trillion-dollar revenue business, and we may have two of them in the next 5-10 years.”

“has emerged as a significant business with a revenue run rate in the tens of billions of dollars and is now profitable in its own right”

“We’re going to invest to continue being the leader. We can fund this plan, and I think it will forever change the size of Amazon. It will forever change our revenue.”